301221-56-7

Basic information

• Product Name: 1-Boc-4-(1-hydroxy-2-nitroethyl)piperidine
• Synonyms: 1-Boc-4-(1-hydroxy-2-nitroethyl)piperidine;4-(1-Hydroxy-2-nitroethyl)-1-piperidinecarboxylic acid 1,1-dimethylethyl ester;4-(1-Hydroxy-2-nitro-ethyl)-piperidine-1-carboxylicacidtert-butylester
• CAS NO: 301221-56-7
• Molecular Formula: C₁₂H₂₂N₂O₅
• Molecular Weight: 274.31348
• Mol File: 301221-56-7.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 403.4°C at 760 mmHg
• Flash Point: 197.8°C
• Appearance: /
• Density: 1.189g/cm³
• Vapor Pressure: 3.46E-08mmHg at 25°C
• Refractive Index: 1.503
• CAS DataBase Reference: 1-Boc-4-(1-hydroxy-2-nitroethyl)piperidine(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Boc-4-(1-hydroxy-2-nitroethyl)piperidine(301221-56-7)
• EPA Substance Registry System: 1-Boc-4-(1-hydroxy-2-nitroethyl)piperidine(301221-56-7)

Safety Data

• Hazardous Substances Data: 301221-56-7(Hazardous Substances Data)

Usage

General Description

1-Boc-4-(1-hydroxy-2-nitroethyl)piperidine is a chemical compound with the molecular formula C14H24N2O5. It is a derivative of piperidine that contains a tert-butoxycarbonyl (Boc) protecting group, a hydroxyl group, and a nitroethyl group. 1-Boc-4-(1-hydroxy-2-nitroethyl)piperidine is used in organic synthesis and medicinal chemistry as a building block for the synthesis of various pharmaceutical compounds. It can also serve as a precursor for the synthesis of bioactive molecules and pharmaceutical drugs. The presence of the nitro group in this compound makes it potentially useful as a nitroalkane precursor in organic chemistry reactions. Overall, 1-Boc-4-(1-hydroxy-2-nitroethyl)piperidine has significant utility in the field of organic chemistry and drug development.

InChI:InChI=1/C12H22N2O5/c1-12(2,3)19-11(16)13-6-4-9(5-7-13)10(15)8-14(17)18/h9-10,15H,4-8H2,1-3H3

Upstream product

• 75-52-5 nitromethane 
• 137076-22-3 tert butyl 4-formylpiperidine-1-carboxylate 
• 865-47-4 potassium tert-butylate 

Downstream Products

• 301221-57-8 tert-butyl 4-(2-amino-1-hydroxyethyl)piperidine-1-carboxylate? 
• 301221-60-3 1-t-butyloxycarbonyl-4-(2-benzyl-thiazol-5-yl)piperidine 
• 301221-59-0 1-t-butyloxycarbonyl-4-(2-phenylacetamido)acetyl-piperidine 
• 301221-58-9 4-(1-hydroxy-2-phenylacetylamino-ethyl)-piperidine-1-carboxylic acid tert-butyl ester 
• 1312081-79-0 (S,E)-tert-butyl 4-(1-nitro-3-oxo-5-phenylpent-4-en-2-yl)piperidine-1-carboxylate 
• 1429500-82-2 tert-butyl 4-{2-[(2,4-dimethoxybenzyl)amino]-1-hydroxyethyl}piperidine-1-carboxylate 
• 1429500-83-3 tert-butyl 4-(2-{(2,4-dimethoxybenzyl)[(4-iodo-1H-pyrrol-2-yl)carbonyl]amino}-1-hydroxyethyl)piperidine-1-carboxylate 
• 1429500-84-4 tert-butyl 4-(2-{(2,4-dimethoxybenzyl)[(4-iodo-1H-pyrrol-2-yl)carbonyl]amino}-1-[(methylsulfonyl)oxy]ethyl)piperidine-1-carboxylate 
• 1429500-85-5 tert-butyl 4-[2-(2,4-dimethoxybenzyl)-7-iodo-1-oxo-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazin-4-yl]piperidine-1 carboxylate 
• 1429501-76-7 tert-butyl 4-{2-(2,4-dimethoxybenzyl)-1-oxo-7-[3-(trifluoromethoxy)phenyl]-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazin-4-yl}piperidine-1-carboxylate 
• 1439359-04-2 tert-butyl 4-((2R,3S)-5-ethoxy-1-nitro-5-oxo-3-phenylpentan-2-yl)piperidine-1-carboxylate 

Relevant articles and documents

Discovery of Small-Molecule Inhibitors of Ubiquitin Specific Protease 7 (USP7) Using Integrated NMR and in Silico Techniques

USP7 is a deubiquitinase implicated in destabilizing the tumor suppressor p53, and for this reason it has gained increasing attention as a potential oncology target for small molecule inhibitors. Herein we describe the biophysical, biochemical, and comput

4-ALKYL SUBSTITUTED 3,4-DIHYDROPYRROLO[1,2-a]PYRAZIN-1(2H)-ONE DERIVATIVES AS KINASES INHIBITORS

The present invention relates to 4-alkyl substituted 3,4-dihydropyrrolo[1,2-a]pyrazin-1(2H)-one derivatives which modulate the activity of protein kinases and are therefore useful in treating diseases caused by dysregulated protein kinase activity. The present invention also provides methods for preparing these compounds, pharmaceutical compositions comprising these compounds, and methods of treating diseases utilizing such these compounds or the pharmaceutical compositions containing them

INHIBITORS OF SPHINGOSINE KINASE

The present invention relates to compounds of the formula (I), in which R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12,